-
PONV treatment
- Anticholinergics
- Benzamides
- Butyrophenones
- NK1 antagonist
- Phenothiazines
- Serotonin antagonist
-
CINV treatment
- Anticholinergics
- Benzamides
- Cannabinoids
- NK1 antagonist
- serotonin antagonist
-
RINV treatment
- Anticholinergics
- serotonin antagonist
-
MNV treatment
- Antihistamines
- Benzamides
- Phenothiazines
-
CINV (High emetic risk regimens)
- 5-HT3 antagonist on day 1
- Dexamethasone days 1-4
- Apreptiant days 1,2,3
-
CINV (moderate emetic risk regimens)
- 5-HT3 antagonist on day 1
- dexamethasone days 1,(2,3)
- Aprepitant days 1,2,3
-
CINV (low emetic risk regimens)
dexamethasone day 1
-
PONV regimens
- prophylaxis:
- serotonin antagonist
- dexamethasone
- or droperidol
-
RINV (High emetic risk regimens)
serotonin antagonist + dexamethasone for prophylaxis
-
RINV ( moderate to low emetic risk regimens)
serotonin antagonist for prophylaxis
-
Ondasetron ( Zofran) Dosage form
- 4mg & 8mg tablet and ODT
- 4mg/5ml oral soln
- 2mg/ml inj./ preservative free inj.
-
Dolsateron (Anzemet) dosage form
- 20mg/ml inj.
- 50 & 100mg tablets
-
Gransetron ( Kytril) dosage form
- 1mg tablet
- 3.1mg/24 hour transdermal patch
- 2mg/10ml oral solution
- 1mg/ml inj
- 0.1mg/ml preservative free inj.
-
Palonsetron ( Aloxi) dosage form
- 0.5mg capsule
- 0.05mg/ml inj.
|
|
